<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Clinical nephrology</journal-id><journal-title-group><journal-title xml:lang="en">Clinical nephrology</journal-title><trans-title-group xml:lang="ru"><trans-title>Клиническая нефрология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-3594</issn><issn publication-format="electronic">2414-9322</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">273831</article-id><article-id pub-id-type="doi">10.18565/nephrology.2021.2.67-71</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Assessment of the risk of developing complications of type 2 diabetes mellitus in the Azerbaijani population using various formulas to calculate the glomerular filtration rate</article-title><trans-title-group xml:lang="ru"><trans-title>Оценка риска развития осложнений сахарного диабета 2 типа в азербайджанской популяции при использовании различных формул для расчета скорости клубочковой фильтрации</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Akhmedova</surname><given-names>Ziba G.</given-names></name><name xml:lang="ru"><surname>Ахмедова</surname><given-names>Зиба-Бегим Гулам кызы</given-names></name></name-alternatives><bio xml:lang="en"><p>Dr. Sci. (Med.), endocrinologist, Associate Professor at the Department of Therapy with the course of Endocrinolog</p></bio><bio xml:lang="ru"><p>д.м.н., врач эндокринолог, доцент кафедры терапии с курсом эндокринологии</p></bio><email>еndo.ziba@qmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Mekhtiev</surname><given-names>Tofik V.</given-names></name><name xml:lang="ru"><surname>Мехтиев</surname><given-names>Тофик Вахид оглы</given-names></name></name-alternatives><bio xml:lang="en"><p>Dr. Sci. (Med.), Head of the Endocrinology Department</p></bio><bio xml:lang="ru"><p>д.м.н., заведующий эндокринологическим отделением</p></bio><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Azerbaijan State Advanced Training Institute for Doctors named after A. Aliev</institution></aff><aff><institution xml:lang="ru">Азербайджанский государственный институт усовершенствования врачей им. А. Алиева</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Shaki Central District Hospital</institution></aff><aff><institution xml:lang="ru">Центральная районная больница г. Шеки</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2021</year></pub-date><volume>13</volume><issue>2</issue><issue-title xml:lang="en">VOL 13, NO2 (2021)</issue-title><issue-title xml:lang="ru">ТОМ 13, №2 (2021)</issue-title><fpage>67</fpage><lpage>71</lpage><history><date date-type="received" iso-8601-date="2023-02-22"><day>22</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, ООО «Бионика Медиа»</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/2075-3594/article/view/273831">https://journals.eco-vector.com/2075-3594/article/view/273831</self-uri><abstract xml:lang="en"><p>Objective. Evaluation of alternative methods for calculating GFR in patients with type 2 diabetes mellitus (DM2) in the Azerbaijani population and identification the most informative ones. Material and methods. The study involved 186 ethnic Azerbaijanis with DM2 (age 55.8±7.7 years, DM2 duration - 5.6±3.2 years). A biochemical analyzer was used for clinical and laboratory examination. Microalbuminuria was determined by the immunochemical method. Statistical analysis was performed using Statistica 6.0 software. Results. The CKD-EPI formula was characterized by the smallest range and variability in GFR. When using the Cockroft-Gault formula, a significant overestimation of the calculated GFR values was noted. Clinical parallels between GFR parameters according to alternative calculation formulas and the clinical manifestations of diabetic nephropathy (DN) confirmed a progressive decrease in GFR in albuminuria. Clinical parallels between GFR and lipid spectrum, and highly sensitive C-reactive protein level were demonstrated. Conclusions. It is preferable to calculate GFR in an on-line calculator to identify DN in DM2. The greatest "consistency" of the CKD-EPI and MDRD formulas was revealed, especially at GFR &lt;60 ml/min/1.78 m2. A correlation between the calculation of GFR using alternative formulas and the increase in clinical manifestations of DN, as well as the values of GFR with indicators of lipotoxicity and inflammation were established.</p></abstract><trans-abstract xml:lang="ru"><p>Цель исследования. Оценить альтернативные способы расчета СКФ у пациентов с СД2 азербайджанской популяции и выявить наиболее информативные. Материал и методы. Обследованы 186 этнических азербайджанцев с СД2 (возраст - 55,8±7,7 года, длительность СД2 - 5,6±3,2 года). Для клинико-лабораторного обследования использован биохимический анализатор. Микроальбуминурия определена иммунохимическим методом. Статистический анализ выполнен в программе Statistica 6.0. Результаты. Формула CKD-EPI характеризуется наименьшим размахом значений и вариабельностью СКФ. При использовании формулы KГ отмечено достоверное завышение расчетных величин СКФ. Клинические параллели между параметрами СКФ по альтернативным формулам расчета и клиническими проявлениями ДН подтвердили прогрессивное снижение СКФ при альбуминурии. Показаны клинические параллели между СКФ и липидным спектром, уровнем высокочувствительного С-реактивного белка. Выводы. Предпочтителен расчет СКФ в on-line-калькуляторе для выявления ДН при СД2. Выявлена наибольшая «согласованность» формул CKD-EPI и MDRD, особенно при СКФ&lt;60 мл/мин/1,78 м2. Установлена корреляция между расчетом СКФ по альтернативным формулам и нарастанием клинических проявлений ДН, а также величин СКФ с показателями липотоксичности и воспаления.</p></trans-abstract><kwd-group xml:lang="en"><kwd>MDRD</kwd><kwd>CKD-EPI</kwd><kwd>type 2 diabetes mellitus</kwd><kwd>diabetic nephropathy</kwd><kwd>MDRD</kwd><kwd>CKD-EPI</kwd><kwd>microalbuminuria</kwd><kwd>Azerbaijanis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>сахарный диабет 2 типа</kwd><kwd>диабетическая нефропатия</kwd><kwd>микроальбуминурия</kwd><kwd>азербайджанцы</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Болотова Е. В., Самородская И.В., .Дудникова А.В. и др. Распространенность снижения скорости клубочковой фильтрации среди трудоспособного населения Краснодара. Клиническая нефрология. 2014;3:14-18</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Abdulrhman Aldukhayel. Prevalence of diabetic nephropathy among Type 2 diabetic patients in some of the Arab countries. Int J Health Sci (Qassim). 2017; 11(1):1-4.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Клочкова Е.В., Толмачева А.А., Чернова Н.Н. и др. Диабетическая нефропатия и хроническая болезнь почек при сахарном диабете 2 типа. Сибирское медицинское обозрение. 2019;(5):29-32. Doi: 10.20333/2500136-2019-5-29-32</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Jiang S., Fang J., Yu T. et al. Novel Model Predicts Diabetic Nephropathy in Type 2 Diabetes. Am J Nephrol. 2020;51(2):130-138. Doi: 10.1159/000505145.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Мухин Н.А. Снижение скорости клубочковой фильтрации - общепопуляционный маркер неблагоприятного прогноза. Терапевтический архив. 2007;6:5-10.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Науэль Р.Т., Детерева О.А., Каюков И.Г. и др. К проблеме оценки величины скорости клубочковой фильтрации у пациентов с хронической болезнью почек. Нефрология. 2011;15(1):104-109.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Шестакова М.В. Сахарный диабет и хроническая болезнь почек: современная диагностика и лечение. Вестник РАМН. 2012; (1):45-49.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Delanaye P, Cavalier E., Mariat C. et al. MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant? BMC Nephrol. 2010;11:8. Doi: 10.1186 / 1471-2369-11-8.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Gaspari F., Ruggenenti P., Porrini E. et al. The GFR and GFR decline cannot be accurately estimated in type 2 diabetics. Kidney International. 2013; 84(1):164-173. Doi: 10.1038/ki.2013.47</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Matsushita K, Tonelli M., Lloyd A. et al. Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) Study equation for estimated GFR. Am J Kidney Dis. 2012;60(2):241-249. DOI: 10.1053/j.aakd.2012.03.016.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Shafi T., Matsushita K., Selvin E. et al. Comparing the association of GFR estimated by the CKD-EPI and MDRD study equations and mortality: the third national health and nutrition examination survey (NHANES III). BMC Nephrol. 2012;13:42. Doi: 10.1186/1471-2369-13-42.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Tamura M.K., Anand S., Li S. et al. Comparison of CKD awareness in a screening population using the Modification of Diet in Renal Disease (MDRD) study and CKD Epidemiology Collaboration (CKD-EPI) equations. Am J Kidney Dis. 2011 Mar;57(3 Suppl 2):S17-23. Doi: 10.1053/j.ajkd.2010.11.008.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Targher G., Zoppini G., Mantovani W. et al. Comparison of two creatinine-based estimating equations in predicting all-cause and cardiovascular mortality in patients with type 2 diabetes. Diabetes Care. 2012;35(11):2347-2353. Doi: 10.2337/dc12-0259.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Arora P., Rajagopalan S., Patel N. et al. The MDRD equation underestimates the prevalence of CKD among blacks and overestimates the prevalence of CKD among whites compared to the CKD-EPI equation: a retrospective cohort study. BMC Nephrol. 2012;13:4. Doi: 10.1186 / 1471-2369-13-4</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Stevens L.A., Schmid C.H., Greene T. et al. Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis. 2010;56(3):486-495. Doi: 10.1053/j.ajkd.2010.03.026.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Keane W.F., Tomassini J.E., Neff D.R. Lipid abnormalities in patients with chronic kidney disease: implications for the pathophysiology of atherosclerosis. JAtheroscler Thromb. 2013;20(2):123-133. Doi: 10.5551/jat.12849.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>de Vries A.P., Ruggenenti P., Ruan X.Z. et al. Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol. 2014;2(5):417-426. Doi: 10.1016 S2213-8587 (14) 70065-8.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Батюшин М.М. Методические основы оценки скорости клубочковой фильтрации в урологической практике. Вестник урологии. 2017;5(1):42-51. Doi: 10.21886/2306-6424-2017-5-1-42-51</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Bjornstad P, Cherney D.Z., Maahs D.M. Update on estimation of kidney function in diabetic kidney disease. Curr Diab Rep. 2015 Sep;15(9):57. Doi: 10.1007/s11892-015-0633-2</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Mbarawa Marat Kofia Ibrahim, Marcellin Guiaro Ndoe, Lawan Loubou Mohamadou Institute of Medical Research A Comparison of three Methods to Estimate the Glomerular Filtration Rate in Diabetic Patients at the Ngaoundere Regional Hospital (Cameroon). International Journal of Health and Biological Sciences. 2019;2(1);6-10.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Levey A.S., Eckfeldt J.H. Using Glomerular Filtration Rate Estimating Equations: Clinical and Laboratory Considerations. Clin Chem. 2015;61(10):1226-1229. Doi: 10.1373 / Clinchem.2015.245282</mixed-citation></ref></ref-list></back></article>
